Programming of obesity and cardiovascular disease

被引:75
|
作者
Remacle, C [1 ]
Bieswal, F [1 ]
Reusens, B [1 ]
机构
[1] Catholic Univ Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium
关键词
foetal programming; cardiovascular disease; animal models;
D O I
10.1038/sj.ijo.0802800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: There is evidence that malnutrition in early life induces a growth retardation leading, in adult life, to manifest components of the metabolic syndrome. However, the impact on obesity seems less clearly established. OBJECTIVE: To review the effects of foetal and postnatal malnutrition on the programming of obesity in the context of the metabolic syndrome, as well as the link between central obesity and cardiovascular diseases. METHODS: Included in the review were recent papers exploring the mechanisms linking maternal nutrition with impaired foetal growth and later obesity, cardiovascular disease, hypertension and diabetes in humans and animals. RESULTS: The programming of obesity during foetal and early postnatal life depends of the timing of maternal malnutrition as well as the postnatal environment. Obesity arises principally in offspring submitted to malnutrition during early stages of gestation and which presented early catch-up growth. The programming may involve the dysregulation of appetite control or the hormonal environment leading to a context favourable to obesity development ( hypersecretion of corticosteroids, hyperinsulinaemia and hyperleptinaemia and anomalies in the IGF axis). Adipose tissue secretes actively several factors implicated in inflammation, blood pressure, coagulation and fibrinolysis. The programmed development of intra-abdominal obesity after early growth restriction may thus favour higher prevalence of hypertension and cardiovascular diseases. CONCLUSIONS: Abdominal obesity appears in malnourished offspring and is aggravated by early catch-up growth. Higher rates of intra-abdominal obesity observed after growth restriction may participate to hypertension and create atherothrombotic conditions leading to the development of cardiovascular diseases.
引用
收藏
页码:S46 / S53
页数:8
相关论文
共 50 条
  • [31] Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
    Bastien, Marjorie
    Poirier, Paul
    Lemieux, Isabelle
    Despres, Jean-Pierre
    PROGRESS IN CARDIOVASCULAR DISEASES, 2014, 56 (04) : 369 - 381
  • [32] Leptin as a Key between Obesity and Cardiovascular Disease
    Kang, Ki-Woon
    Ok, Minho
    Lee, Seong-Kyu
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2020, 29 (04) : 248 - 259
  • [33] Impact of obesity and diabetes on health and cardiovascular disease
    Lecube, Albert
    ATENCION PRIMARIA, 2024, 56 (12):
  • [34] Association of cardiovascular disease with overweight and obesity in Spain
    Guallar-Castillón, P
    Banegas, JRB
    de Yébenes, MJG
    Gutiérrez-Fisac, JL
    García, EL
    Rodríguez-Artalejo, F
    MEDICINA CLINICA, 2002, 118 (16): : 616 - 618
  • [35] Immune Cell Activation in Obesity and Cardiovascular Disease
    Garcia, Jamie N.
    Wanjalla, Celestine N.
    Mashayekhi, Mona
    Hasty, Alyssa H.
    CURRENT HYPERTENSION REPORTS, 2022, 24 (12) : 627 - 637
  • [36] Programming of cardiovascular disease across the life-course
    Blackmore, Heather L.
    Ozanne, Susan E.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 83 : 122 - 130
  • [37] The obesity paradox: Understanding the effect of obesity on mortality among individuals with cardiovascular disease
    Banack, Hailey R.
    Kaufman, Jay S.
    PREVENTIVE MEDICINE, 2014, 62 : 96 - 102
  • [38] Programming effects of FTO in the development of obesity
    Sebert, S.
    Salonurmi, T.
    Keinanen-Kiukaanniemi, S.
    Savolainen, M.
    Herzig, K-H
    Symonds, M. E.
    Jarvelin, M-R
    ACTA PHYSIOLOGICA, 2014, 210 (01) : 58 - 69
  • [39] Mineralocorticoids and Cardiovascular Disease in Females with Insulin Resistance and Obesity
    Nayyar, Manav
    Lastra, Guido
    Acevedo, Camila Manrique
    CURRENT HYPERTENSION REPORTS, 2018, 20 (10)
  • [40] Obesity and cardiovascular disease: an ESC clinical consensus statement
    Koskinas, Konstantinos C.
    Van Craenenbroeck, Emeline M.
    Antoniades, Charalambos
    Blueher, Matthias
    Gorter, Thomas M.
    Hanssen, Henner
    Marx, Nikolaus
    McDonagh, Theresa A.
    Mingrone, Geltrude
    Rosengren, Annika
    Prescott, Eva B.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, : 184 - 220